The Problem With Most Healthcare AI Products
The AI vendor landscape in healthcare operations has arrived at a particular failure mode: every platform now has an AI story, but most of those stories are the same story. The AI summarizes your data. The AI generates a report. The AI answers questions about your KPIs via a natural language interface. These are demonstration features — things that look compelling in a sales environment and add modest utility in production. They are not the AI that changes operational outcomes.
Operators who’ve been through an AI vendor evaluation cycle in the last two years have a version of the same frustration: the demo showed something impressive, the production deployment showed a dashboard with a different paint job, and the team was still doing the same manual work they’d always done.
AI that changes healthcare operational outcomes is narrow, embedded, and always-on. It does specific things exceptionally well, and it does them continuously, without requiring a human to request the output. It doesn’t produce insights — it produces inputs to actions, at the moment the action is needed.
What Embedded AI Actually Looks Like
In credentialing, the AI that matters is not a calendar that watches expiration dates — that’s a rules engine, and most credentialing software already has one. The genuine AI application in credentialing is automated primary source verification: reading state licensing board portals, payer portals, OIG LEIE exclusion files, and SAM debarment records programmatically, then surfacing discrepancies without human retrieval. The other real AI application is payer correspondence parsing — extracting enrollment status, effective dates, and approval decisions from unstructured payer letters, roster returns, and fax-based responses. These are the tasks where language models compress actual human hours and reduce the documentation error rate that creates downstream enrollment problems.
In revenue cycle, the AI that matters is denial prediction and appeal support. A model that scores individual claims before submission for denial risk — based on the specific history of that payer, that procedure code, that provider enrollment status, that diagnosis sequence — enables a pre-submission triage that a rules engine can’t replicate. The rules engine can flag known failure patterns; the model can surface novel ones emerging from payer behavior changes.
Two details are critical for any denial prediction system. First, precision matters as much as recall. A high false-positive rate in a denial prediction model creates a different operational problem: it floods the triage queue with low-risk claims that require human review, adding workload rather than reducing it. Before adopting any denial prediction tool, ask what the false positive rate is at the operating threshold and what the remediation workflow looks like for flagged claims. Second, the value of an AI-assisted appeal is not drafting speed — it’s overturn rate. A faster appeal that overturns at the same rate as a human-drafted appeal saves time; an appeal that overturns at a higher rate creates real revenue recovery. Those are different claims, and the distinction matters in a vendor evaluation.
What makes AI in this context work is not the model — it’s the operational data underneath it. A denial prediction model needs years of payer-specific claims history. An appeal support system needs to have ingested thousands of payer policy documents, adjudication rules, and clinical coverage determinations. That corpus takes years to build. You can’t buy it in a year, and you can’t build it without running the operation.
Data Governance: The Question Before the Demo
Before any AI vendor conversation reaches the demo stage, one set of questions has to be answered. Does the vendor’s model train on client data? If so, is client data isolated or shared across the training pool? Does the BAA cover the AI processing layer, or only the underlying platform? What are the data retention policies for inputs to the AI, and what happens to prompts and outputs in the vendor’s infrastructure?
These aren’t abstract concerns. A model trained on aggregated client data improves from your organization’s claims history, payer patterns, and clinical context — and that improvement also benefits the vendor’s other clients, including competitors. The tradeoff may be acceptable; the business terms and BAA language are where you learn whether it’s disclosed and bounded.
The Test Worth Running
The practical evaluation of any AI claim in a healthcare operations vendor conversation should produce four answers before you sign. First, can they show you the alert log with timestamps — alerts surfaced before a problem occurred, with the date the alert fired and the date the problem would have materialized? Second, what is the false positive rate on denial predictions at the operating threshold, and what does the remediation workflow look like for flagged claims? Third, what is the appeal overturn rate for AI-assisted appeals versus the baseline, and is that measured in the client’s own claim history or in aggregate? Fourth, what percentage of AI-drafted appeals are submitted without material edit by the clinical or billing team?
If the answer to any of these is a pivot to the dashboard, the AI is a reporting layer. The demo is not the product; the answers are.
Before signing any healthcare operations AI agreement, ask for the alert log with timestamps, the false positive rate on denial predictions, the appeal overturn delta versus baseline, and the BAA coverage for the AI processing layer.